Search research articles
Contact Us
Filters
Showing results (471-480 of 632) with videos related to
Page
of 64
Sort By:
Diagnostics (Basel, Switzerland)
|
April 30, 2021
Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate Cancer
Wajahat Khatri, Hyun Woo Chung, Rudolf A Werner, et al.
Annals of Nuclear Medicine
|
March 17, 2019
<sup>18</sup>F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies
Sara Sheikhbahaei, Krystyna M Jones, Rudolf A Werner, et al.
The Journal of Biological Chemistry
|
May 12, 2005
Unraveling the mechanism of a potent transcriptional activator
Zhen Lu, Steven P Rowe, Brian B Brennan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 10, 2016
Semiquantitative Parameters in PSMA-Targeted PET Imaging with <sup>18</sup>F-DCFPyL: Variability in Normal-Organ Uptake
Xin Li, Steven P Rowe, Jeffrey P Leal, et al.
Nuklearmedizin. Nuclear Medicine
|
January 14, 2022
[18F]DCFPyL PET/CT for Imaging of Prostate Cancer
Steven P Rowe, Andreas Buck, Ralph A Bundschuh, et al.
Radiology
|
March 31, 2021
Prostate-specific Membrane Antigen PET in Prostate Cancer
Courtney Lawhn-Heath, Ali Salavati, Spencer C Behr, et al.
Toxins
|
April 23, 2020
Defensive Venoms: Is Pain Sufficient for Predator Deterrence?
Crystal N Niermann, Travis G Tate, Amber L Suto, et al.
Radiologic Clinics of North America
|
November 16, 2023
Prostate-Specific Membrane Antigen-Ligand Therapy: What the Radiologist Needs to Know
Steven P Rowe, Mohammad S Sadaghiani, Andrei Gafita, et al.
Clinical Nuclear Medicine
|
May 11, 2023
Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors
Alexander Weich, Sebastian E Serfling, Wiebke Schlötelburg, et al.
Nuklearmedizin. Nuclear Medicine
|
August 17, 2022
Clinical Utility of C-Reactive Protein and White Blood Cell Count for Scheduling an [18F]FDG PET/CT in Patients with Giant Cell Arteritis
Konstanze V Guggenberger, Marius L Vogt, Steven P Rowe, et al.
Page
of 64
Search research articles
Search
Showing results (471-480 of 632) with videos related to
Sort By:
Page
of 64
Diagnostics (Basel, Switzerland)
|
April 30, 2021
Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate Cancer
Wajahat Khatri, Hyun Woo Chung, Rudolf A Werner, et al.
Annals of Nuclear Medicine
|
March 17, 2019
<sup>18</sup>F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies
Sara Sheikhbahaei, Krystyna M Jones, Rudolf A Werner, et al.
The Journal of Biological Chemistry
|
May 12, 2005
Unraveling the mechanism of a potent transcriptional activator
Zhen Lu, Steven P Rowe, Brian B Brennan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 10, 2016
Semiquantitative Parameters in PSMA-Targeted PET Imaging with <sup>18</sup>F-DCFPyL: Variability in Normal-Organ Uptake
Xin Li, Steven P Rowe, Jeffrey P Leal, et al.
Nuklearmedizin. Nuclear Medicine
|
January 14, 2022
[18F]DCFPyL PET/CT for Imaging of Prostate Cancer
Steven P Rowe, Andreas Buck, Ralph A Bundschuh, et al.
Radiology
|
March 31, 2021
Prostate-specific Membrane Antigen PET in Prostate Cancer
Courtney Lawhn-Heath, Ali Salavati, Spencer C Behr, et al.
Toxins
|
April 23, 2020
Defensive Venoms: Is Pain Sufficient for Predator Deterrence?
Crystal N Niermann, Travis G Tate, Amber L Suto, et al.
Radiologic Clinics of North America
|
November 16, 2023
Prostate-Specific Membrane Antigen-Ligand Therapy: What the Radiologist Needs to Know
Steven P Rowe, Mohammad S Sadaghiani, Andrei Gafita, et al.
Clinical Nuclear Medicine
|
May 11, 2023
Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors
Alexander Weich, Sebastian E Serfling, Wiebke Schlötelburg, et al.
Nuklearmedizin. Nuclear Medicine
|
August 17, 2022
Clinical Utility of C-Reactive Protein and White Blood Cell Count for Scheduling an [18F]FDG PET/CT in Patients with Giant Cell Arteritis
Konstanze V Guggenberger, Marius L Vogt, Steven P Rowe, et al.
Page
of 64